IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Ponoi II Management, LLC

Q2 2022 Holdings

Filed 2022-08-12 | 4 holdings | $36.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
NGM Biopharmaceuticals Inc(NGMUSD)COM62921N105$16.7K1,298,90845.2%
Revolution Medicines Inc(RVMD)COM76155X100$13.4K685,01136.3%
Nurix Therapeutics Inc(NRIX)COM67080M103$4.1K327,12311.3%
Rapt Therapeutics Inc(RAPTEUR)COM75382E109$2.7K145,4017.2%